magnifying glass
logo for BioTheraVision


Get Full Access

Who is BioTheraVision

BioTheraVision, Inc. (BTV) is a privately held, pre-clinical stage pharmaceutical company focused on developing ophthalmic therapeutics. Our approach is to repurpose known molecules through unleashing hidden potentials to treat ocular diseases where practitioners and patients are still vastly frustrated with current treatments. Our lead product candidates are BTV100 for treating ocular dry eye disease and BT300 for treating post-ocular surgery inflammation. BioTheraVision is based in Chicago, Illinois and is led by a team of pharmaceutical experts who have years of ocular drug development and drug delivery experience. BTV currently has 6 patents pending in the U.S. for its portfolio of projects.Read More



420 N Wabash Ave, Ste 539, Chicago, Illinois, 60611, United States




$6 Million
SIC Code 2834,283
NAICS Code 32541,325
Popular Searches:

BioTheraVision Inc

Biotheravision LLC


Illustration of an envelope

BioTheraVision's Tech Stack

GoDaddy DNS


GoDaddy Web Hosting


Google Font API



Font Awesome


Font Awesome
See more technologies

Frequently Asked Questions regarding BioTheraVision

Where are BioTheraVision’s headquarters?

BioTheraVision’s headquarters are in 420 N Wabash Ave, Ste 539, Chicago, Illinois, 60611, United States

What is BioTheraVision’s official website?

BioTheraVision’s official website is

What is BioTheraVision’s Revenue?

BioTheraVision’s revenue is $6 Million

What is BioTheraVision’s SIC code?

BioTheraVision’s SIC: 2834,283

What is BioTheraVision’s NAICS code?

BioTheraVision’s NAICS: 32541,325

How many employees are working in BioTheraVision?

BioTheraVision has 30 employees

What is BioTheraVision’s industry?

BioTheraVision is in the industry of: Drug Manufacturing & Research, Pharmaceuticals, Healthcare

What is BioTheraVision's tech stack?

The technologies that are used by BioTheraVision are: GoDaddy DNS, GoDaddy Web Hosting, Google Font API, Font Awesome

Who is BioTheraVision's CEO?

BioTheraVision's CEO is Andreas Bodmeier

See more information about BioTheraVision
4.4/5 on G2 Crowd